Kyle Kuvalanka – Biography
Last update: January 19, 2026Executive profile
Kyle was Chief Financial and Operating Officer at Goldfinch Bio, and Chief Operating Officer at Syros Pharmaceuticals. Kyle Kuvalanka joined Rome Therapeutics in 2025.
Kyle Kuvalanka is currentlyChief Financial Officer and Chief Business Officer at Rome Therapeutics - View - Rome Therapeutics org chart
Chief Financial Officer at Aktis Oncology - View - Aktis Oncology org chart
Create your alert
to follow the career of Kyle Kuvalanka.
Education
Kyle Kuvalanka has a Bachelor of Arts in College of Social Studies from Wesleyan University in 1990 and a Master of Business Administration in Strategy and Finance from University of Pennsylvania in 2000.
They have also studied at Wesleyan University :
Find more alumni from Wesleyan University
They have also studied at University of Pennsylvania :
Find more alumni from University of Pennsylvania
More about Kyle Kuvalanka
Selected links
Do you need to know more about Kyle Kuvalanka? More results.
Participate
Social media
- Kyle Kuvalanka on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Kyle Kuvalanka
The colleagues of Kyle Kuvalanka
Company Colleagues
- At Rome Therapeutics, Kyle Kuvalanka has 13 colleagues including Rosana Kapeller (CEO & Director), Jeb Keiper (Director)…
- At Aktis Oncology, Kyle Kuvalanka has 31 colleagues including Matthew Roden (CEO & Director), Glenn Gormley (Director)…
Industry Colleagues
- In the Biotechnology industry, Kyle Kuvalanka has 35,756 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Kyle Kuvalanka.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Kyle Kuvalanka.
